Literature DB >> 2201519

Phencyclidine.

E B Baldridge1, H A Bessen.   

Abstract

Patients intoxicated with phencyclidine (PCP) present both diagnostic and management dilemmas. The clinical presentation ranges from coma to severe agitation and violence; disorientation, psychosis, catatonia and bizarre behavior can be seen. Patients are at-risk for significant medical complications such as rhabdomyolysis, seizures, and hyperthermia. This article reviews the effects and complications of PCP abuse and offers an approach to the management of these patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2201519

Source DB:  PubMed          Journal:  Emerg Med Clin North Am        ISSN: 0733-8627            Impact factor:   2.264


  11 in total

1.  High-dose glycine treatment of refractory obsessive-compulsive disorder and body dysmorphic disorder in a 5-year period.

Authors:  W Louis Cleveland; Robert L DeLaPaz; Rashid A Fawwaz; Roger S Challop
Journal:  Neural Plast       Date:  2010-02-18       Impact factor: 3.599

Review 2.  Glutamatergic autoencephalitides: an emerging field.

Authors:  Jessica A Panzer; Amy J Gleichman; David R Lynch
Journal:  J Neural Transm (Vienna)       Date:  2014-01-09       Impact factor: 3.575

3.  Organic catatonia: a review.

Authors:  N Ahuja
Journal:  Indian J Psychiatry       Date:  2000-10       Impact factor: 1.759

4.  Changes in gene expression after phencyclidine administration in developing rats: a potential animal model for schizophrenia.

Authors:  F Liu; X Zou; N Sadovova; X Zhang; L Shi; L Guo; F Qian; Z Wen; T A Patterson; J P Hanig; M G Paule; W Slikker; C Wang
Journal:  Int J Dev Neurosci       Date:  2010-08-05       Impact factor: 2.457

5.  Anti-N-Methyl-D-Aspartate Receptor Encephalitis: Neuropsychiatric and Multidisciplinary Approach to a Patient Not Responding to First-Line Treatment.

Authors:  Arsen S Askandaryan; Abbas Naqvi; Amanda Varughese; Dina Rimawi
Journal:  Cureus       Date:  2022-06-08

Review 6.  Vaccines against drugs of abuse: a viable treatment option?

Authors:  Kathleen M Kantak
Journal:  Drugs       Date:  2003       Impact factor: 9.546

7.  NMDA receptor function, memory, and brain aging.

Authors:  J W Newcomer; N B Farber; J W Olney
Journal:  Dialogues Clin Neurosci       Date:  2000-09       Impact factor: 5.986

8.  Schizophrenia proteomics: biomarkers on the path to laboratory medicine?

Authors:  Shaheen Emmanuel Lakhan
Journal:  Diagn Pathol       Date:  2006-07-17       Impact factor: 2.644

Review 9.  Anti-N-methyl-d-aspartate receptor encephalitis: review of clinical presentation, diagnosis and treatment.

Authors:  Helen Barry; Susan Byrne; Elizabeth Barrett; Kieran C Murphy; David R Cotter
Journal:  BJPsych Bull       Date:  2015-02

10.  In reply:.

Authors:  David Feifel; Michael P Wilson; David Pepper; Glenn W Currier; Garland Holloman
Journal:  West J Emerg Med       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.